Prism 5This page contains information on Prism 5 for veterinary use.
The information provided typically includes the following:
- Prism 5 Indications
- Warnings and cautions for Prism 5
- Direction and dosage information for Prism 5
Prism 5This treatment applies to the following species:
Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Vaccine
Modified Live and Killed Virus
For Veterinary Use Only
Prism 5 Indications
For vaccination of healthy cattle as an aid in the prevention of disease caused by bovine rhinotracheitis virus, bovine virus diarrhea (types 1 and 2), bovine parainfluenza 3, and bovine respiratory syncytial virus. This vaccine may be used in pregnant cows or calves nursing pregnant cows provided the cows were vaccinated pre-breeding, according to label instructions, with Pyramid 5, Pyramid 10, or Pyramid 3.
Contains IBR, PI3, and BRSV modified live viruses, and inactivated BVD types 1 and 2. Contains neomycin, polymyxin B, and thimerosal as preservatives.
Prism 5 Dosage And Administration
Aseptically rehydrate the modified live virus vaccine with the accompanying diluent. Shake well. Inject one 2 mL dose subcutaneously, using aseptic technique. Cattle should be revaccinated after 14 to 28 days with a 2 mL booster dose of Prism® 5. Annual revaccination is recommended. Protect animals from exposure for at least 14 days after vaccination. Calves vaccinated under 6 months of age should be revaccinated at 6 months of age.
Summary Of Pregnant Cow Safety Study
Safety in pregnant cows and heifers was demonstrated in trials conducted in three separate herds of more than 1,400 cows. Prior to breeding, all animals were vaccinated with Pyramid® 5, a modified live virus (MLV) vaccine containing IBR, BVD types 1 & 2, PI3, and BRSV. During the first, second or third trimester of pregnancy, the animals were vaccinated again. The pregnant cows received either Pyramid 5 or a killed virus (KV) IBR, BVD type 1 & 2, PI3, and BRSV vaccine (Triangle® 5). From pregnancy vaccination through calving, the cows were observed for fetal loss. Fetal loss in both groups was similar with 0.9% in the Pyramid 5 vaccinated groups and 1.6% in the KV vaccinated groups. In addition, no abortions due to IBR or BVD were identified in either group. Following birth, each calf’s health was monitored for 30 days. The health of calves born to Pyramid 5 vaccinated dams was similar to the health of calves born to the KV vaccinated dams. Fetal health risks associated with vaccination of pregnant animals with modified live vaccines cannot be unequivocally determined by clinical trials conducted for Iicensure. Vaccination of pregnant animals with modified live vaccines should be discussed with a veterinarian.
Store in the dark at 35 - 45°F (2 - 7°C). Avoid freezing. Use entire contents when first opened. A small percentage of animals may show transient mild injection site swelling. Do not vaccinate within 21 days before slaughter. Burn containers and all unused contents. In case of anaphylactoid reaction, administer epinephrine.
Prism® is a registered trademark of Boehringer Ingelheim Vetmedica, Inc.
U.S. Patent Nos. 5,733,555 - 5,958,423
© 2010 Boehringer Ingelheim Vetmedica, Inc. All Rights Reserved.
Boehringer Ingelheim Vetmedica, Inc., St. Joseph, MO 64506
U.S. Vet. License No. 124
10 Doses/Rehydrate to 20 mL
This package contains one 10 dose vial of MLV vaccine and one 20 mL vial of diluent.
50 Doses/Rehydrate to 100 mL
This package contains one 50 dose vial of MLV vaccine and one 100 mL vial of diluent.
2621 NORTH BELT HIGHWAY, ST. JOSEPH, MO, 64506-2002
|Every effort has been made to ensure the accuracy of the Prism 5 information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.|
Copyright © 2017 North American Compendiums. Updated: 2017-10-31